Joshua Sharfstein, MD

Vice Dean, Public Health Practice and Community Engagement; Professor, Practice in Health Policy and Management; Director, Bloomberg American Health Initiative, Johns Hopkins Bloomberg School of Public Health

Dr. Joshua Sharfstein is the Vice Dean for Public Health Practice and Community Engagement, Professor of the Practice in Health Policy and Management, and Director of the Bloomberg American Health Initiative at the Johns Hopkins Bloomberg School of Public Health. Previously, he served as Secretary of the Maryland Department of Health and Mental Hygiene from January 2011 to December 2014. In this position, he led the development of a new fatality review process for overdose deaths and spearheaded interagency data sharing on addiction. From March 2009 to January 2011, Dr. Sharfstein served as Principal Deputy Commissioner of the U.S. Food and Drug Administration, where he oversaw the agency’s successful performance management and transparency initiatives. From December 2005 to March 2009, as Commissioner of Health for Baltimore City, Dr. Sharfstein led innovative efforts that contributed to major declines in both overdose deaths and infant mortality rates. From July 2001 to December 2005, as a minority professional staff and health policy advisor for Congressman Henry A. Waxman, he was engaged in a wide range of oversight and legislative activities on health care topics.